1、Lili Yang#, Shanshan Liu#, Jingjing Chu, Shuang Miao, Kai Wang, Qingwei Zhang, Yingyi Wang, Yadi Xiao, Lina Wu, Yang Liu, Longjian Yu, Caihong Yu, Xiang Liu, Mingxing Ke, Zhen Cheng*, Xilin Sun*. Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancer. Biomater Sci. 2021 Jan 21;9(2):443-455.
2、Li-Li Yang#, Bing-Chen Liu, Xiao-Yu Lu, Yan Yan, Yu-Jia Zhai, Qing Bao, Paul W. Doetsch, Xingming Deng, Tiffany L. Thai, Abdel A. Alli, Douglas C. Eaton, Bao-Zhong Shen, He-Ping Ma. Inhibition of TRPC6 reduces non-small cell lung cancer cell proliferation and invasion. Oncotarget. 2017, 8(3): 5123-5134.
3、Bing-Chen Liu, Li-Li Yang#, Xiao-Yu Lu, Xiang Song, Xue-Chen Li, Guangping Chen, Yichao Li, Xincheng Yao, Donald R Humphrey, Douglas C Eaton, Bao-Zhong Shen, and He-Ping Ma. Lovastatin-induced phosphatidylinositol-4-phosphate 5-kinase diffusion from microvilli stimulates ROMK channels. J Am Soc Nephrol. 2015 Jul;26(7):1576-87.